Mirum Pharmaceuticals, Inc. (MIRM)
86.08
+0.07
(+0.08%)
USD |
NASDAQ |
Oct 12, 16:00
86.08
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Free Cash Flow (Quarterly) : -69.28M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -69.28M |
| March 31, 2026 | -239.43M |
| December 31, 2025 | 5.467M |
| September 30, 2025 | 39.49M |
| June 30, 2025 | 11.91M |
| March 31, 2025 | -2.002M |
| December 31, 2024 | -5.088M |
| September 30, 2024 | -6.197M |
| June 30, 2024 | -14.58M |
| March 31, 2024 | 15.20M |
| December 31, 2023 | -21.62M |
| September 30, 2023 | -18.22M |
| June 30, 2023 | -17.40M |
| March 31, 2023 | -33.82M |
| December 31, 2022 | -34.51M |
| Date | Value |
|---|---|
| September 30, 2022 | -26.04M |
| June 30, 2022 | -20.19M |
| March 31, 2022 | -39.67M |
| December 31, 2021 | -52.15M |
| September 30, 2021 | -34.22M |
| June 30, 2021 | -40.20M |
| March 31, 2021 | -25.21M |
| December 31, 2020 | -36.31M |
| September 30, 2020 | -17.50M |
| June 30, 2020 | -17.05M |
| March 31, 2020 | -18.45M |
| December 31, 2019 | -13.76M |
| September 30, 2019 | -15.39M |
| June 30, 2019 | -8.017M |
| March 31, 2019 | -2.47M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Incyte Corp. | 495.25M |
| Insmed, Inc. | -95.09M |
| Galectin Therapeutics, Inc. | -2.439M |
| Kodiak Sciences, Inc. | -46.59M |
| Praxis Precision Medicines, Inc. | -78.21M |